Last reviewed · How we verify

NCT03722095

Research on the Effects of Combined Neurostimulation Protocols on Stress

Completed NA Last updated 30 November 2021
What this trial tests

NA trial testing active tDCS in Stress Reaction in 74 participants. Completed in 31 October 2020.

Timeline
29 October 2018
Primary endpoint
31 October 2020
31 October 2020

Quick facts

Lead sponsorUniversity Ghent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposeother
Enrollment74
Start date29 October 2018
Primary completion31 October 2020
Estimated completion31 October 2020
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Ghent

Who can join

Adults 18 to 45, any sex, with Stress Reaction or Stress Related Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study examines the effects of the combined use of two different non-invasive brain stimulation (NIBS) techniques targeting the DLPFC on stress reactivity and recovery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of active tDCS

Trials testing the same drug.

Other recruiting trials for Stress Reaction

Currently open trials in the same condition.

Other University Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03722095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing